We are live on ! Find out more
MSCM

McElhenny Sheffield Capital Management Portfolio holdings

AUM $404M
1-Year Est. Return 19.8%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+19.8%
3 Year Est. Return
+86.26%
5 Year Est. Return
+137.95%
10 Year Est. Return
–
AUM
$216M
AUM Growth
+$85M
Cap. Flow
+$921M
Cap. Flow %
426.42%
Top 10 Hldgs %
67.78%
Holding
660
New
573
Increased
18
Reduced
46
Closed
4

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$742M
2
TXN icon
Texas Instruments
TXN
+$56.2M
3
IWV icon
iShares Russell 3000 ETF
IWV
+$33.3M
4
MSMR icon
McElhenny Sheffield Managed Risk ETF
MSMR
+$29.7M
5
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$17.6M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$2.71M
2
USDU icon
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
+$2.71M
3
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$1.89M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.42M
5
HON icon
Honeywell
HON
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 6.76%
2 Healthcare 5.53%
3 Consumer Discretionary 5.07%
4 Energy 5.07%
5 Consumer Staples 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KKR icon
626
KKR & Co
KKR
$99.6B
$557 ﹤0.01%
+12
New +$585
AFG icon
627
American Financial Group
AFG
$12B
$549 ﹤0.01%
+4
New +$548
ISEE
628
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$535 ﹤0.01%
+25
New +$534
ZLAB icon
629
Zai Lab
ZLAB
$2.92B
$522 ﹤0.01%
+17
New +$536
ZBRA icon
630
Zebra Technologies
ZBRA
$18.1B
$513 ﹤0.01%
+2
New +$517
ALT icon
631
Altimmune
ALT
$583M
$510 ﹤0.01%
+31
New +$348
HRMY icon
632
Harmony Biosciences
HRMY
$2.3B
$496 ﹤0.01%
+9
New +$495
INSM icon
633
Insmed
INSM
$29B
$480 ﹤0.01%
+24
New +$464
NEO icon
634
NeoGenomics
NEO
$2.12B
$480 ﹤0.01%
+52
New +$485
BLD
635
DELISTED
TopBuild
BLD
$469 ﹤0.01%
+3
New +$477
VST icon
636
Vistra
VST
$48.6B
$464 ﹤0.01%
+20
New +$463
TTC icon
637
Toro Company
TTC
$9.41B
$453 ﹤0.01%
+4
New +$424
COLL icon
638
Collegium Pharmaceutical
COLL
$843M
$441 ﹤0.01%
+19
New +$383
ELAN icon
639
Elanco Animal Health
ELAN
$11.4B
$440 ﹤0.01%
+36
New +$449
ALB icon
640
Albemarle
ALB
$15.3B
$434 ﹤0.01%
+2
New +$533
BHVN
641
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$430 ﹤0.01%
+31
New +$4.71K
AZPN
642
DELISTED
Aspen Technology Inc
AZPN
$411 ﹤0.01%
+2
New +$465
CINF icon
643
Cincinnati Financial
CINF
$26.6B
$410 ﹤0.01%
+4
New +$412
CERE
644
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$410 ﹤0.01%
+13
New +$367
TWLO icon
645
Twilio
TWLO
$39.3B
$392 ﹤0.01%
+8
New +$455
SILK
646
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$370 ﹤0.01%
+7
New +$341
CTLT
647
DELISTED
CATALENT, INC.
CTLT
$360 ﹤0.01%
+8
New +$435
SITE icon
648
SiteOne Landscape Supply
SITE
$4.32B
$352 ﹤0.01%
+3
New +$349
BMEA icon
649
Biomea Fusion
BMEA
$93.5M
$329 ﹤0.01%
+39
New +$333
ICUI icon
650
ICU Medical
ICUI
$4.55B
$315 ﹤0.01%
+2
New +$304
23 24 25
26
27

Similar funds

NFG
Northeast Financial Group Tannersville, Pennsylvania $404M AUM 12.61% 1-Year Est. Return
MI
M3F Inc Salt Lake City, Utah $404M AUM 17.6% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $404M AUM
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
BC
Bridgefront Capital Austin, Texas $402M AUM 18.17% 1-Year Est. Return
EPAM
Evelyn Partners Asset Management London $406M AUM 19.36% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
PCP
Perbak Capital Partners London, United Kingdom $406M AUM 17.25% 1-Year Est. Return

McElhenny Sheffield Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, McElhenny Sheffield Capital Management held 660 positions worth $216M, up 65% from $131M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

McElhenny Sheffield Capital Management deployed $921M of net new capital in Q4 2022, opening 573 new positions and adding to 18 existing holdings. Its largest new stake was Starbucks: 7,863,922 shares worth $7.96M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, down from 6.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was SPDR Gold Trust, an estimated $2.71M trimmed.

  • McElhenny Sheffield Capital Management's largest Q4 2022 buy was Starbucks: 7,863,922 shares worth $7.96M.
  • McElhenny Sheffield Capital Management added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $17.6M increase.
  • McElhenny Sheffield Capital Management's biggest Q4 2022 reduction was SPDR Gold Trust, cutting an estimated $2.71M.
  • McElhenny Sheffield Capital Management fully exited Nasdaq in Q4 2022, selling an estimated $875K.
  • McElhenny Sheffield Capital Management's ten largest holdings make up 68% of its $216M portfolio in Q4 2022.
  • McElhenny Sheffield Capital Management opened 573 new positions and closed 4 in Q4 2022.
  • McElhenny Sheffield Capital Management's portfolio value rose 65% quarter-over-quarter to $216M.

Based on McElhenny Sheffield Capital Management's 13F filing for Q4 2022, filed 11 Jan 2023.